Literature DB >> 3511445

Long-term outcome of group B streptococcal meningitis.

E R Wald, I Bergman, H G Taylor, D Chiponis, C Porter, K Kubek.   

Abstract

Group B Streptococcus is a common cause of neonatal sepsis and meningitis. The purpose of this study was to evaluate the neurologic, psychologic, and academic status of children who had group B streptococcal meningitis and to compare these children with their siblings. Seventy-four children who acquired group B streptococcal meningitis between one day and 6 months of life formed the study population. Survivors were 3 to 18 years old at the time of their follow-up evaluations. Twenty children (27%) died, two were institutionalized, one severely affected child died at age 2 years, 15 were assessed by phone interview, and two were lost to follow-up. Thirty-four children and 21 siblings were comprehensively evaluated with physical and neurologic examinations, hearing tests, and tests of intellectual, perceptual-motor, and behavioral-adaptive functions. Of the total population, nine children (12%) had major neurologic sequelae (spastic quadraplegia, profound mental retardation, hemiparesis, deafness, or blindness). Six children had acute hydrocephalus; two were doing well after shunt placement. In general, those children surviving group B streptococcal meningitis without major sequelae appeared to be functioning normally or comparably to their sibling in intellectual, social, and academic matters.

Entities:  

Mesh:

Year:  1986        PMID: 3511445

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  13 in total

1.  Long term outcome of neonatal meningitis.

Authors:  J P Stevens; M Eames; A Kent; S Halket; D Holt; D Harvey
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-05       Impact factor: 5.747

Review 2.  Early identification of neuro-developmental disorders.

Authors:  P D Singhi
Journal:  Indian J Pediatr       Date:  1992 Jan-Feb       Impact factor: 1.967

Review 3.  Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis.

Authors:  Matthijs C Brouwer; Allan R Tunkel; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

4.  Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus.

Authors:  M R Wessels; L C Paoletti; D L Kasper; J L DiFabio; F Michon; K Holme; H J Jennings
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

5.  Characteristics and immediate outcome of childhood meningitis treated in the pediatric intensive care unit.

Authors:  Folafoluwa O Odetola; Susan L Bratton
Journal:  Intensive Care Med       Date:  2004-11-23       Impact factor: 17.440

6.  Factors influencing neurological outcome of children with bacterial meningitis at the emergency department.

Authors:  Fatiha Bargui; Irene D'Agostino; Patricia Mariani-Kurkdjian; Corinne Alberti; Catherine Doit; Nathalie Bellier; Laurence Morin; Giuliano Galli Gibertini; Assia Smail; Anna Zanin; Mathie Lorrot; Stéphane Dauger; Mathieu Neve; Albert Faye; Priscilla Armoogum; Antoine Bourrillon; Edouard Bingen; Jean-Christophe Mercier; Stéphane Bonacorsi; Lise E Nigrovic; Luigi Titomanlio
Journal:  Eur J Pediatr       Date:  2012-04-19       Impact factor: 3.183

7.  Neonatal E. coli infection causes neuro-behavioral deficits associated with hypomyelination and neuronal sequestration of iron.

Authors:  Jacqueline C Lieblein-Boff; Daniel B McKim; Daniel T Shea; Ping Wei; Zhen Deng; Caroline Sawicki; Ning Quan; Staci D Bilbo; Michael T Bailey; Dana M McTigue; Jonathan P Godbout
Journal:  J Neurosci       Date:  2013-10-09       Impact factor: 6.167

Review 8.  Epidemiology of group B streptococcal disease in the United States: shifting paradigms.

Authors:  A Schuchat
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

9.  Burden of invasive group B Streptococcus disease and early neurological sequelae in South African infants.

Authors:  Ziyaad Dangor; Sanjay G Lala; Clare L Cutland; Anthonet Koen; Lisa Jose; Firdose Nakwa; Tanusha Ramdin; Joy Fredericks; Jeannette Wadula; Shabir A Madhi
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

10.  Should Israel screen all mothers-to-be to prevent early-onset of neonatal group B streptococcal disease? A cost-utility analysis.

Authors:  Gary M Ginsberg; Arthur I Eidelman; Eric Shinwell; Emilia Anis; Reuven Peyser; Yoram Lotan
Journal:  Isr J Health Policy Res       Date:  2013-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.